Company: LHI
Filing Date: 2025-09-29
Form Type: F-1/A
Source: 0001213900-25-092499
Chunk: 97

Company: Living Homeopathy International Ltd.
Filing Date: 2025-09-29
Form: F-1/A
Chunk 97
---
 may by ordinary resolution declare a dividend, but no dividend may exceed the amount recommended by our board of directors. Even if our board of directors decides to pay dividends, the form, frequency and amount will depend upon our future operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions and other factors that the board of directors may deem relevant. Please see the section entitled “Taxation” beginning on page 116 of this prospectus for information on the potential tax consequences of any cash dividends declared.

<div align='center'>51

CAPITALIZATION</div>

The following table sets forth our capitalization
as of March 31, 2025:

| ● | on                   
 an actual basis; and |

| ● | on an as adjusted basis                                                                                                             
 to reflect the issuance and sale of 1,250,000 Class A Ordinary Shares by us in this offering at the assumed initial public offering 
 price of $5.00 per Class A Ordinary Share, which is the midpoint of the estimated initial public offering price range set forth on  
 the cover page of this prospectus, after deducting the estimated underwriting discounts and the estimated offering expenses payable 
 by Living Homeopathy.                                                                                                               |

You should read this table together with our
consolidated financial statements and the related notes included elsewhere in this prospectus and the information under “Management’s
Discussion and Analysis of Financial Condition and Results of Operations.” beginning on page 56 of this prospectus.

|                                                                                                                                   |     | March 31, 2025 |           |   |     |          |           |   |
|:----------------------------------------------------------------------------------------------------------------------------------|:----|:---------------|----------:|:--|:----|:---------|----------:|:--|
|                                                                                                                                   |     | Actual         |           |   |     | Adjusted |           |   |
|                                                                                                                                   |     | US$            |           |   |     | US$      |           |   |
| Shareholders’ equity:                                                                                                             |     |                |           |   |     |          |           |   |
| Class A Ordinary Shares, US$0.0001 par value, authorized                                                                          
 450,000,000 shares and 9,000,000 shares issued and outstanding on actual basis as of March 31, 2025; 10,250,000 shares issued and 
 outstanding, as adjusted to reflect the 50,000,000 Class A Ordinary Shares issued and outstanding as of March 31, 2025